Graham Capital Management, L.P. Precigen, Inc. Transaction History

Graham Capital Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.89 - $1.41 $3,271 - $5,183	-3,676 Reduced 18.92%	15,758 $21,000
Q3 2023 Nov 22, 2023	SELL	$1.08 - $1.85 $18,028 - $30,882	-16,693 Reduced 46.21%	19,434 $27,000
Q2 2023 Aug 14, 2023	BUY	$0.96 - $1.4 $34,681 - $50,577	36,127 New	36,127 $41,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $785,859 - $1.55 Million	-557,347 Reduced 89.98%	62,082 $131,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $2.53 $156,636 - $344,601	136,206 Added 28.19%	619,429 $830,000
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $889,481 - $1.85 Million	465,697 Added 2657.18%	483,223 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $61,866 - $96,393	17,526 New	17,526 $65,000
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $1.93 Million - $2.54 Million	-309,467 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $2.09 Million - $3.39 Million	309,467 New	309,467 $2.13 Million

143

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $354M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.